New Test Can Detect Patients’ Risk of Harmful Side Effects from Alzheimer’s Drugs
A new PCR-based test accurately predicts Alzheimer’s patients’ genetic predisposition to side effects from anti-amyloid drugs.
Read MorePosted by Andy Lundin | Aug 1, 2024 | Dementias & Alzheimer’s |
A new PCR-based test accurately predicts Alzheimer’s patients’ genetic predisposition to side effects from anti-amyloid drugs.
Read MorePosted by Andy Lundin | Jul 31, 2024 | Lab Automation |
The new survey from Siemens and The Harris Poll highlights the potential of automation to alleviate lab burnout and improve efficiency.
Read MorePosted by Andy Lundin | Jul 29, 2024 | Dementias & Alzheimer’s |
Certain blood tests are as accurate as spinal taps and brain scans to detect amyloid plaques, potentially influencing Alzheimer’s diagnosis.
Read MorePosted by Andy Lundin | Jul 26, 2024 | Prostate |
Studies indicate men with BRCA1 and BRCA2 mutations face significant cancer risks, prompting new national screening guidelines.
Read MorePosted by Chris Wolski | Jul 24, 2024 | Sequencing Systems |
The Unlock Behind the Seizure program aims to provide accessible and affordable genetic testing for pediatric epilepsy patients.
Read More